Immune Dysfunction in Multiple Sclerosis:
Modern Considerations in Treatment and Management
For each question, please select the best option.
Items marked with * require a response.
Which of the following is a mechanism that applies to every disease-modifying therapy (DMT), regardless of whether it is classified as an immunosuppressant or an immunomodulator?
Bone marrow suppression
Alteration of immune function
Competitive inhibition of cytokines
Evidence supports testing for antibodies against the John Cunningham virus (JCV) in all patients who are starting treatment with which of the following DMTs?
Natalizumab, fingolimod, or dimethyl fumarate
Any DMT that has been associated with progressive multifocal leukoencephalopathy (PML)